Buyer for a full service biopharmaceutical CRO in Europe

Company to buy

• Size: Medium business
• Sales: 10-60 million EUR
• Location: Europe
• Reason for acquisition: The management wants to expand the business in Europe
• #CFIE PHB233

Overview of buyer for a full-service biopharmaceutical CRO in Europe

Primarily, the company is a leader in the clinical research service market with a long history of success. At this time, the company has a workforce of over 1,000 employees, distributed across offices worldwide.

Profile (strategy) of buyer for a full-service biopharmaceutical CRO in Europe

Foundationally, the company was established about 40 years ago and has since conducted over 10,000 clinical trials for clients in a wide range of industries. More specifically, this includes the pharmaceutical, biotechnology, and medical device sectors. Further, the clinical trials were carried out in a broad range of therapeutic areas, with significant expertise in infectious diseases, vaccines, ophthalmology, oncology, neurology, substance use disorders, and maternal and child health.

Overall, the company is known for its expertise in complex clinical trials. In addition, the company has a strong track record of success in bringing new drugs and devices to market. Likewise, the company is also known for its commitment to quality and its focus on customer service.

Currently, the company has clients in more than 75 countries on six continents with offices around the world. Now, the company employs over 1,000 personnel and has more than 150 million US dollars in revenue.

Activities and products of suitable targets

Above all, the buyer is seeking a full-service CRO in Europe with experience in biopharmaceuticals with a positive EBITDA. Moreover, the company is looking for a target that can offer a complementary range of services, including clinical trials, pharmacovigilance, and consulting services. Ideally, the buyer company is also looking for a target with a strong presence in Europe. Strategically, the acquisition of a full-service CRO in Europe would be a beneficial opportunity for the company. Consequently, the company could expand its range of services and become an even more important player in the European market.

Highlights

• Full-service CRO offering a comprehensive range of services, including clinical trial design and development, regulatory affairs, site selection and management, data management and statistical analysis, medical writing and reporting, and pharmacovigilance
• Expertise in complex clinical trials
• Strong track record of success in bringing new drugs and devices to market
• Global workforce

More information on this buyer for a full service biopharmaceutical CRO in Europe

Please get in touch if you are interested in learning more about this buyer for a full service biopharmaceutical CRO in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.